Trials / Unknown
UnknownNCT02800746
Intravenous Iron Pre-treatment in Prognathic Surgery
Preoperative Intravenous Iron Supplementation on Postoperative Hematocrit and Intraoperative Transfusion Amount in Prognathic Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Konkuk University Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The objective of the present study is to determine the impact of preoperative IV-iron (ferric carboxy maltose) supplementation on postoperative hematocrit values and allogenic blood transfusion amount in patients undergoing elective prognathic surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferric carboxymaltose | Ferric carboxymaltose 15 mg/kg mg is intravenously administered on 7-10 day before surgery. |
| DRUG | Placebo | normal saline 100 ml is intravenously administered on 7-10 day before surgery |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2016-06-15
- Last updated
- 2018-03-20
Source: ClinicalTrials.gov record NCT02800746. Inclusion in this directory is not an endorsement.